Company
Every investor coverage indicates participated in a round PainChek raised.
Companies PainChek acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Philip Daffas | CEO | Dealroom |
Stories naming PainChek. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
ASX-listed digital health firm PainChek has agreed to raise 5.5 million dollars via convertible notes from prior shareholders, funding working capital and a North American sales push after signing a US aged-care deal.
Techboard's monthly roundup logs June 2022 Australian funding events, including GO1's Series E, Edrolo's Series B, two acquisitions, several new funds reaching closes, and accelerator intake announcements.
Also Techboard
Techboard's annual report finds Australian early-stage startup funding passed $10 billion in FY21, up 64%, while WA companies attracted just $50 million, with ASX raises dominating and female founders' funding share falling.
Deal promotion inviting certified investors into NVISO's convertible loan raise ahead of a planned 2019 ASX listing; EverBlu Capital and its principals have already put in $180,000 alongside existing fund managers.